Key result
High expression of lncRNA AB073614 in ovarian cancer patients was associated with shorter 5-year overall survival compared to low expression.
Observational (n=75)
No
The long noncoding RNA AB073614 acts as an oncogene in ovarian cancer, promoting tumorigenesis and predicting poor overall survival.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for AB073614 as ovarian cancer biomarker; animal data leaves clinical validation open.
// Zhongping Cheng 1, 2 , Jing Guo 1, 2 , Li Chen 1, 2 , Ning Luo 1, 2 , Weihong Yang 1, 2 , Xiaoyan Qu 1, 2 1 Department of Obstetrics and Gynecology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, PR China 2 Institute of Gynecological Minimally Invasive Medicine, Tongji University School of Medicine, Shanghai, PR China Correspondence to: ZhongPing Cheng, e-mail: mdcheng18@263.net Keywords: lincRNA, AB073614, ovarian cancer, RNAi Received: March 20, 2015 Accepted: July 17, 2015 Published: July 30, 2015 ABSTRACT Long noncoding RNA (lncRNA) profiles in ovarian cancer (OC) remain largely unknown. In the present study, we screened AB073614 as a new candidate lncRNA which promotes development of OC, in two independent datasets (GSE18521 and GSE38666) from the Gene Expression Omnibus (GEO). The level of AB073614 was then detected in 75 paired OC tissues and adjacent normal tissues by qRT-PCR. Results showed that AB073614 expression was significantly up-regulated in 85.3% (64/75) cancerous tissues compared with normal counterparts ( P < 0.01). Further, the 5-year overall survival (OS) in OC patients with high expression of AB073614 was inferior to that with low expression (17.2 months vs 30.0 months, P = 0.0025). To investigate the functional role of AB073614, AB073614 siRNA was transfected into OC cell lines. Knockdown of AB073614 expression significantly inhibited cell proliferation and invasion, resulted in cell arrest in G 1 phase of cell cycle and a dramatic increase of apoptosis, both in HO-8910 and OVCAR3 cells. In vivo experiment also revealed that knockdown AB073614 inhibited OVCAR3 cells proliferation. Finally, western blot assays indicated that lncRNA AB073614 may exert its function by targeting ERK1/2 and AKT-mediated signaling pathway. In conclusion, our study suggests that lncRNA AB073614 acts as a functional oncogene in OC development.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2015) conducted an observational in Ovarian cancer (n=75). High expression of AB073614 vs. Low expression of AB073614 was evaluated on 5-year overall survival (OS) (p=0.0025). High expression of lncRNA AB073614 in ovarian cancer patients was associated with shorter 5-year overall survival compared to low expression.
Synapse has enriched 10 related papers. Consider them for comparative context: